Medtronic plans to buy SPR Therapeutics for $650 million to expand pain treatment options

Medical device maker Medtronic said on Wednesday ​it plans to ‌acquire privately held SPR Therapeutics for about $650 million in cash, expanding ​its portfolio of ​treatments for chronic pain.

Reuters • 6 hours ago

Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain

Acquisition will enhance Medtronic's Neuromodulation portfolio with temporary peripheral nerve stimulation (PNS) technology, enabling earlier intervention for chronic pain sufferers GALWAY, Ireland, May 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global healthcare technology leader, today announced its intent to acquire SPR Therapeutics, Inc. (SPR), a privately held medical technology company and a recognized leader in temporary, percutaneous peripheral nerve stimulation (PNS) therapies for chronic pain management. The transaction consists of an upfront cash payment of approximately $650 million for all the outstanding equity in SPR.

PRNewsWire • 8 hours ago

2 High-Yield Healthcare Stocks to Buy Before They Raise Payouts

Both offer dividends that yield well above the current S&P 500 index average of 1.1%. The first company is already a Dividend King, while the other is very close to joining that celebrated group.

The Motley Fool • May 19, 2026

Silver Economy Investing: Why the Healthcare Giants Are in Focus

Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.

Zacks Investment Research • May 19, 2026

Medtronic (MDT) Advances While Market Declines: Some Information for Investors

The latest trading day saw Medtronic (MDT) settling at $77.32, representing a +1.54% change from its previous close.

Zacks Investment Research • May 18, 2026

A Once-in-a-Decade Opportunity: 1 Stock to Buy Hand Over Fist and Hold for Years

With a 3.7% yield and 48 consecutive annual dividend increases, this medical device maker will interest long-term dividend investors. Value investors, meanwhile, will appreciate the fact that the stock's P/S, P/E, and P/B ratios are all below their five-year averages.

The Motley Fool • May 17, 2026

Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom

Surgical robotics is quietly becoming an artificial intelligence story. Every robotic procedure generates structured video, kinematic, and outcomes data that platforms feed back into surgeon training, intraoperative guidance, and predictive analytics.

24/7 Wall Street • May 15, 2026

Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks.

Even as tech surges, many other sectors in the market are trading at surprisingly attractive prices.

Barrons • May 15, 2026

Medtronic (MDT) Stock Drops Despite Market Gains: Important Facts to Note

In the closing of the recent trading day, Medtronic (MDT) stood at $74.54, denoting a -2.11% move from the preceding trading day.

Zacks Investment Research • May 11, 2026

3 Stocks With Monster Potential to Hold Through the Next Decade of Uncertainty

Shipping giant United Parcel Service is facing new competition from Amazon, but it still has a great brand and turnaround appeal. Innovative protein-focused food maker Hormel Foods is starting to get back on track.

The Motley Fool • May 10, 2026